Mitopure (Urolithin A)
Mitopure is a proprietary form of urolithin A, a postbiotic compound that activates mitophagy to remove damaged mitochondria and enhance cellular energy production. It specifically targets muscle cells and neurons to improve physical performance, reduce fatigue, and support cognitive function through optimized mitochondrial health.
Origin & History
Mitopure is a proprietary form of Urolithin A, a metabolite derived from ellagitannins found in pomegranates and other fruits. It is produced through a patented process to ensure purity and efficacy.
Historical & Cultural Context
Urolithin A is a compound that has been studied for its role in autophagy and cellular health, with roots in traditional uses of pomegranate in various cultures.
Health Benefits
- Enhances cellular energy by improving mitochondrial function, leading to increased vitality and reduced fatigue. - Supports muscle health by promoting muscle endurance and recovery, reducing muscle fatigue by 15% in studies. - Boosts cognitive function by enhancing brain mitochondrial activity, improving memory and focus. - Promotes healthy aging by reducing cellular senescence, contributing to longevity and vitality. - Improves cardiovascular health by enhancing endothelial function, reducing the risk of heart disease. - Supports metabolic health by improving insulin sensitivity, aiding in weight management. - Reduces inflammation by modulating inflammatory pathways, contributing to joint and overall systemic health.
How It Works
Urolithin A activates the PINK1-Parkin pathway to trigger mitophagy, the selective removal of damaged mitochondria from cells. This process stimulates mitochondrial biogenesis through PGC-1α activation, leading to improved ATP production and enhanced cellular energy metabolism. The compound also modulates AMPK signaling pathways to optimize metabolic efficiency in muscle and brain tissues.
Scientific Research
Clinical studies have shown that Mitopure can improve mitochondrial function and muscle endurance, with ongoing research exploring its potential for healthy aging.
Clinical Summary
Human clinical trials with 500-1000mg daily doses of Mitopure showed 15% reduction in muscle fatigue and improved exercise endurance in older adults over 4-month periods. Studies included randomized, double-blind, placebo-controlled trials with sample sizes ranging from 60-100 participants aged 40-70 years. Biomarker analysis confirmed increased mitochondrial gene expression and improved cellular energy metabolism. Evidence is promising but limited to short-term studies in specific populations.
Nutritional Profile
{"bioactive_compounds": {"urolithin A": "500 mg per serving"}, "bioavailability_notes": "Urolithin A is a metabolite derived from ellagitannins found in certain fruits and nuts, with bioavailability influenced by gut microbiota composition. Absorption can vary significantly among individuals."}
Preparation & Dosage
A common dosage is 500 mg per day. Consult a healthcare provider before use.
Synergy & Pairings
Coenzyme Q10, PQQ, Resveratrol
Safety & Interactions
Mitopure urolithin A is generally well-tolerated with minimal reported side effects in clinical studies. Mild gastrointestinal symptoms including nausea or stomach discomfort may occur during initial supplementation. No significant drug interactions have been documented, though potential interactions with mitochondrial-affecting medications should be monitored. Safety during pregnancy and breastfeeding has not been established, so use should be avoided in these populations.